Literature DB >> 32281407

Catheter Ablation in Patients With Cardiogenic Shock and Refractory Ventricular Tachycardia.

Jad A Ballout1, Oussama M Wazni2, Khaldoun G Tarakji2, Walid I Saliba2, Mohamed Kanj2, Mohamed Diab2, Mandeep Bhargava2, Bryan Baranowski2, Thomas J Dresing2, Thomas D Callahan2, Daniel J Cantillon2, John Rickard2, David O Martin2, Niraj Varma2, Mark J Niebauer2, Mina K Chung2, Patrick J Tchou2, Bruce D Lindsay2, Ayman A Hussein2.   

Abstract

BACKGROUND: There is paucity of data regarding radiofrequency ablation for ventricular tachycardia (VT) in patients with cardiogenic shock and concomitant VT refractory to antiarrhythmic drugs on mechanical support.
METHODS: Patients undergoing VT ablation at our center were enrolled in a prospectively maintained registry and screened for the current study (2010-2017).
RESULTS: All 21 consecutive patients with cardiogenic shock and concomitant refractory ventricular arrhythmia undergoing bailout ablation due to inability to wean off mechanical support were included. Median age was 61 years, 86% were men, median left ventricular ejection fraction was 20%, 81% had ischemic cardiomyopathy, and PAINESD score was 18±5. The type of mechanical support in place before the procedure was intra-aortic balloon pump in 14 patients (67%), Impella CP in 2, extracorporeal membrane oxygenation in 2, extracorporeal membrane oxygenation and intra-aortic balloon pump in 2, and extracorporeal membrane oxygenation and Impella CP in 1. Endocardial voltage maps showed myocardial scar in 19 patients (90%). The clinical VTs were inducible in 13 patients (62%), whereas 6 patients had premature ventricular contraction-induced ventricular fibrillation/VT (29%), and VT could not be induced in 2 patients (9%). Activation mapping was possible in all 13 with inducible clinical VTs. Substrate modification was performed in 15 patients with scar (79%). After ablation and scar modification, the arrhythmia was noninducible in 19 patients (91%). Seventeen (81%) were eventually weaned off mechanical support successfully, but 6 (29%) died during the index admission from persistent cardiogenic shock. Patients who had ventricular arrhythmia and cardiogenic shock on presentation had a trend toward lower in-hospital mortality compared with those who presented with cardiogenic shock and later developed ventricular arrhythmia.
CONCLUSIONS: Bailout ablation for refractory ventricular arrhythmia in cardiogenic shock allowed successful weaning from mechanical support in a large proportion of patients. Mortality remains high, but the majority of patients were discharged home and survived beyond 1 year.

Entities:  

Keywords:  ablation; catheter ablation; heart failure; shock, cardiogenic; tachycardia, ventricular

Mesh:

Substances:

Year:  2020        PMID: 32281407      PMCID: PMC7285871          DOI: 10.1161/CIRCEP.119.007669

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  25 in total

1.  Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation.

Authors:  Paolo Della Bella; Francesca Baratto; Dimitris Tsiachris; Nicola Trevisi; Pasquale Vergara; Caterina Bisceglia; Francesco Petracca; Corrado Carbucicchio; Stefano Benussi; Francesco Maisano; Ottavio Alfieri; Federico Pappalardo; Alberto Zangrillo; Giuseppe Maccabelli
Journal:  Circulation       Date:  2013-02-25       Impact factor: 29.690

2.  Outcomes of rescue cardiopulmonary support for periprocedural acute hemodynamic decompensation in patients undergoing catheter ablation of electrical storm.

Authors:  Andres Enriquez; Jackson Liang; Javier Gentile; Robert D Schaller; Gregory E Supple; David S Frankel; Fermin C Garcia; Joyce Wald; Edo Y Birati; J Eduardo Rame; Christian Bermudez; David J Callans; Francis E Marchlinski; Pasquale Santangeli
Journal:  Heart Rhythm       Date:  2017-09-14       Impact factor: 6.343

3.  Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival.

Authors:  Pasquale Vergara; Roderick Tung; Marmar Vaseghi; Chiara Brombin; David S Frankel; Luigi Di Biase; Koichi Nagashima; Usha Tedrow; Wendy S Tzou; William H Sauer; Nilesh Mathuria; Shiro Nakahara; Kairav Vakil; Venkat Tholakanahalli; T Jared Bunch; J Peter Weiss; Timm Dickfeld; Rama Vunnam; Dhanunjaya Lakireddy; J David Burkhardt; Anna Correra; Pasquale Santangeli; David Callans; Andrea Natale; Francis Marchlinski; William G Stevenson; Kalyanam Shivkumar; Paolo Della Bella
Journal:  Heart Rhythm       Date:  2017-08-24       Impact factor: 6.343

4.  Extracorporeal Membrane Oxygenation for Acute Decompensated Heart Failure.

Authors:  Laurence Dangers; Nicholas Bréchot; Matthieu Schmidt; Guillaume Lebreton; Guillaume Hékimian; Ania Nieszkowska; Sébastien Besset; Jean-Louis Trouillet; Jean Chastre; Pascal Leprince; Alain Combes; Charles-Edouard Luyt
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598

5.  Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.

Authors:  Dagmar M Ouweneel; Erlend Eriksen; Krischan D Sjauw; Ivo M van Dongen; Alexander Hirsch; Erik J S Packer; M Marije Vis; Joanna J Wykrzykowska; Karel T Koch; Jan Baan; Robbert J de Winter; Jan J Piek; Wim K Lagrand; Bas A J M de Mol; Jan G P Tijssen; José P S Henriques
Journal:  J Am Coll Cardiol       Date:  2016-10-31       Impact factor: 24.094

6.  Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock.

Authors:  Justin A Fried; Abhinav Nair; Koji Takeda; Kevin Clerkin; Veli K Topkara; Amirali Masoumi; Melana Yuzefpolskaya; Hiroo Takayama; Yoshifumi Naka; Daniel Burkhoff; Ajay Kirtane; Dimitrios Karmpaliotis; Jeffrey Moses; Paolo C Colombo; A Reshad Garan
Journal:  J Heart Lung Transplant       Date:  2018-03-20       Impact factor: 10.247

7.  Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.

Authors:  Borislav Dinov; Lukas Fiedler; Robert Schönbauer; Andreas Bollmann; Sascha Rolf; Christopher Piorkowski; Gerhard Hindricks; Arash Arya
Journal:  Circulation       Date:  2013-11-08       Impact factor: 29.690

8.  Effectiveness of Extracorporeal Life Support for Patients With Cardiogenic Shock Due To Intractable Arrhythmic Storm.

Authors:  Solène Le Pennec-Prigent; Erwan Flecher; Vincent Auffret; Guillaume Leurent; Jean-Claude Daubert; Christophe Leclercq; Philippe Mabo; Jean-Philippe Verhoye; Raphael P Martins
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

9.  Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1).

Authors:  Marc A Miller; Srinivas R Dukkipati; Jason S Chinitz; Jacob S Koruth; Alexander J Mittnacht; Craig Napolitano; Andre d'Avila; Vivek Y Reddy
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-12-19

10.  Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group.

Authors:  Krishnaraj S Rathod; Sudheer Koganti; M Bilal Iqbal; Ajay K Jain; Sundeep S Kalra; Zoe Astroulakis; Pitt Lim; Roby Rakhit; Miles C Dalby; Tim Lockie; Iqbal S Malik; Charles J Knight; Mark Whitbread; Anthony Mathur; Simon Redwood; Philip A MacCarthy; Alexander Sirker; Constantinos O'Mahony; Andrew Wragg; Daniel A Jones
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2017-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.